Blogs about: 2008 Asco Annual Mtg

Featured Blog

"Dose Dense" Administration of Paclitaxel and Carboplatin Increases Progression Free and Overall Survival in Ovarian Cancer Patients - Is There a New Standard of Care?

“A recent Phase III clinical trial reported that dose dense administration of paclitaxel and carboplatin increased progression free survival (PFS) and overall survival (OS) of ovarian cancer patien… more →

Libby's H*O*P*E*

"Dose Dense" Administration of Paclitaxel and Carboplatin Increases Progression Free and Overall Survival in Ovarian Cancer Patients - Is There a New Standard of Care? — 2 comments

Paul Cacciatore wrote 4 months ago: “A recent Phase III clinical trial reported that dose dense administration of paclitaxel and carb … more →

Tags: Chemotherapy, Clinical Trial Results, Meeting Highlights, clinical trial findings, dose dense, Japanese Gynecological Oncology Group, ovarian cancer, Standard of Care

New Vascular Disrupting Agent In Combination With Avastin Produces a 64% Disease Stabilization Rate in a Small Phase I Solid Tumor Clinical Trial

Paul Cacciatore wrote 5 months ago: In solid tumors, [vascular disrupting agents] VDA’s, such as ZYBRESTAT™, rapidly disrupt th … more →

Tags: Clinical Trial Results, Anti-Vascular Drugs, Pipeline Drugs, Novel Therapies, Zybrestat, fosbretabulin, combretastatin A4-phosphate, CA4P, OXigene

Voreloxin (SNS-595) Produces 48% Disease Stabilization in Treatment Resistant Ovarian Cancer Patients

Paul Cacciatore wrote 5 months ago: Voreloxin (at a 48 mg/m² dosage) demonstrates single agent activity in advanced platinum-resistant … more →

Tags: Clinical Trial Results, Novel Therapies, Meeting Highlights, clear cell, ovarian cancer, SNS-595, voreloxin

2008 American Society of Clinical Oncology (ASCO) Annual Meeting Abstracts Available On-Line

Paul Cacciatore wrote 6 months ago: The 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) will be held on May 30th … more →

Tags: Clinical Trial Results, Early Detection, Gene Therapies, Genetics, Meeting Highlights, Monoclonal Antibody, Novel Therapies, Ovarian Cancer Studies, Pipeline Drugs


Have your say. Start a blog.

See our free features →

Related Tags
All →

Follow this tag via RSS

Find other items tagged with “2008-asco-annual-mtg”:
Technorati Del.icio.us IceRocket